Pricing

TriSalus Life Sciences Inc (TLSI)

followers ยท
Sector: HEALTH CARE
Industry: HEALTH CARE SUPPLIES
CEO: Mary T. Szela
Employees: 106
Web site: trisaluslifesci.com
6272 WEST 91ST AVENUE, WESTMINSTER, CO, 80031
415 336 8917
All 13F Filers Prior Change Hedge Funds 1 Prior Change
TriSalus Life Sciences, Inc., an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors. The company offers the TriNav Infusion System for hepatic arterial infusion of liver tumors; and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors. It also develops SD-101, an investigational immunotherapeutic with pressure-enabled drug delivery technology for hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company is based in Westminster, Colorado.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available